Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

Biotechnology

Healthcare
$2.29 +0.67%

+$0.02 today

Market cap
$165.63M
Beta
0.35
P/E (TTM)
-1.3
EPS (TTM)
-$1.79
52W Low $1.10High $3.60

Volume 0.81M

Average 0.40M

Price history

Acumen Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+46.79%

Period high

$3.37

Period low

$1.56

Latest

$2.29

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KSep 16, 2026Sep 16, 2026
S-8Aug 12, 2026Aug 12, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
4Jun 17, 2026Jun 17, 2026
8-KJun 16, 2026Jun 16, 2026
4Jun 10, 2026Jun 10, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026
4Jun 5, 2026Jun 5, 2026

Competitors

Who does Acumen Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ABOS's filings, answered from its disclosures.

What is the latest ABOS filing?

The latest filing shown is 8-K dated Sep 16, 2026.

How many recent filings does ABOS have?

Intrinsic Alpha currently shows 20 recent filings for ABOS.